Patient Demographic and Schizophrenia Characteristics | Cariprazine 1.5–3 mg/d n = 170 | Cariprazine 4.5–6 mg/d n = 361 | Cariprazine 9 mg/d n = 148 | Cariprazine Overall N = 679 |
---|---|---|---|---|
Age, mean (SD), years | 40.2 (10.6) | 37.9 (10.8) | 38.0 (11.2) | 38.5 (10.9) |
Male, n (%) | 123 (72.4) | 249 (69.0) | 99 (66.9) | 471 (69.4) |
Race, n (%) | ||||
White | 71 (41.8) | 174 (48.2) | 57 (38.5) | 302 (44.5) |
Black | 64 (37.6) | 116 (32.1) | 60 (40.5) | 240 (35.3) |
Asian | 17 (10.0) | 57 (15.8) | 24 (16.2) | 98 (14.4) |
Other | 8 (4.7) | 10 (2.8) | 6 (4.1) | 24 (3.5) |
Missinga | 10 (5.9) | 4 (1.1) | 1 (0.7) | 15 (2.2) |
Weight, mean (SD), kg | 79.26 (19.15) | 77.13 (19.15) | 82.69 (22.81) | 78.88 (20.09) |
Body mass index (BMI), mean (SD), kg/m2 | 26.96 (5.56) | 26.32 (5.43) | 27.82 (6.26) | 26.81 (5.68) |
Duration of schizophrenia, mean (SD), years | 12.9 (10.0) | 11.4 (9.5) | 13.5 (9.9) | 12.2 (9.8) |
Age at onset, mean (SD), years | 27.2 (9.4) | 26.4 (9.2) | 24.4 (8.6) | 26.2 (9.1) |